- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Sangamo Biosciences Inc
Add to PortfolioSGMO:US
4.6100 USD 0.0900 1.99%As of 20:10:00 ET on 05/25/2012.
Snapshot for Sangamo Biosciences Inc (SGMO)
| Open: | 4.5000 | Day's Range: | 4.3900 - 4.6200 | Volume: | 147,181 | Bid: | 4.6100 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 4.5200 | 52wk Range: | 2.3600 - 7.2400 | 1-Yr Rtn: | -30.47% | Ask: | 4.6200 |
Key Statistics for SGMO
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.6400 |
| Est. EPS (USD) (12/2012) | -0.5600 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 242.42 |
| Shares Outstanding (M) | 52.59 |
| Enterprise Value (M USD) (ttm) | 155.82 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 3.2610 |
| Price/Sale (ttm) | 21.2575 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More SGMO Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for SGMO
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for SGMO
Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes. These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences.
| William R Ringo Jr "Bill"Chairman | Edward O Lanphier IIPresident/CEO/Founder |
| H Ward WolffExec VP/CFO | David G IchikawaSenior VP:Business Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page